Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
The lab will offer about 4,000 different tests ranging from basic to high-end molecular diagnostic tests
Board approves fundraise of Rs 1500 crore
In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
New leadership team announced at NATHEALTH Annual General Meeting 2024
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Subscribe To Our Newsletter & Stay Updated